Paid Clinical Trials El Paso
Discover 547 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma
Sponsor:
IDEAYA Biosciences
Location:
Code:
NCT05987332
Conditions
Metastatic Uveal Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
IDE196
Crizotinib
Pembrolizumab
Ipilimumab
Nivolumab
AnifrolumabA 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
Sponsor:
AstraZeneca
Location:
Code:
NCT06015737
Conditions
Cutaneous Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Anifrolumab
Placebo
LY3962673MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06586515
Conditions
Pancreatic Ductal Adenocarcinoma
Non-small Cell Lung Cancer
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3962673
Cetuximab
Gemcitabine
nab-paclitaxel
Oxaliplatin
INBRX-109Study of INBRX-109 in Conventional Chondrosarcoma
Sponsor:
Inhibrx Biosciences, Inc
Location:
Code:
NCT04950075
Conditions
Conventional Chondrosarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
INBRX-109
Placebo
MRTX1719Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT06937970
Conditions
Mesothelioma
Non Small Cell Lung Cancer
Malignant Peripheral Nerve Sheath Tumors
Solid Tumor
Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MRTX1719
Islatravir & LenacapavirStudy to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
Sponsor:
Gilead Sciences
Location:
Code:
NCT06630299
Conditions
HIV-1-Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ISL/LEN
Antiretroviral Combinations
NX-2127A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Sponsor:
Nurix Therapeutics, Inc.
Location:
Code:
NCT04830137
Conditions
Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)
Waldenstrom Macroglobulinemia (WM)
Mantle Cell Lymphoma (MCL)
Marginal Zone Lymphoma (MZL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NX-2127
SonrotoclaxA Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
Sponsor:
BeiGene
Location:
Code:
NCT05952037
Conditions
Waldenstrom Macroglobulinemia
Waldenstrom's Macroglobulinemia Recurrent
Waldenstrom's Macroglobulinemia Refractory
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sonrotoclax
Zanubrutinib
OviTex MeshVentral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Sponsor:
Tela Bio Inc
Location:
Code:
NCT04779918
Conditions
Hernia, Ventral
Hernia, Inguinal
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
OviTex Reinforced Tissue Matrix